Information
-
Trademark
-
88686161
-
Serial Number
88686161
-
Registration Number
6183342
-
International Classifications
-
Filing Date
November 09, 2019
5 years ago
-
Registration Date
October 27, 2020
4 years ago
-
Transaction Date
December 12, 2023
a year ago
-
Status Date
November 08, 2023
a year ago
-
Published for Opposition Date
August 11, 2020
4 years ago
-
Location Date
November 08, 2023
a year ago
-
First Use Anywhere Date
May 01, 2017
7 years ago
-
First Use In Commerce Date
May 01, 2017
7 years ago
-
Status Code
711
-
Current Location
TMO LAW OFFICE 114
Employee Name
JAGANNATHAN, SIDDHARTH
-
Attorney Docket Number
50180.202084
Attorney Name
Cara R. Baer
Law Office Assigned Location Code
M50
-
Owners
Mark Drawing Code
4000
Mark Identification
IMPACT
Case File Statements
- GS0421: Scientific analysis services, namely, neoepitope selection; neoepitope research, development and production of pharmaceuticals comprising personalized adoptive cell therapies; scientific analysis of neoepitopes; research, development and production of pharmaceuticals comprising the selection of and genetic encoding of neoepitopes; research, development and production of pharmaceuticals comprising adoptive cell therapies design of personalized adoptive cell therapies; medical analysis services, namely, detection of truncal cancer mutations in patient tumor cells; developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical product development and evaluation services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials involving neoepitopes; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; Conducting early evaluations in the field of new pharmaceuticals; Providing scientific research advice regarding selection of a neoepitope for the design of a cell therapy and/or immunotherapy product
Case File Event Statements
-
11/9/2023 - a year ago
20 - NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Type: NCS7
-
11/8/2023 - a year ago
19 - CANCELLED SECTION 7-TOTAL
Type: C7..
-
6/16/2023 - a year ago
18 - REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Type: C7RF
-
11/7/2023 - a year ago
17 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
11/7/2023 - a year ago
16 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
6/16/2023 - a year ago
15 - TEAS SECTION 7 SURRENDER RECEIVED
Type: ES7S
-
10/27/2020 - 4 years ago
14 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
8/11/2020 - 4 years ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
8/11/2020 - 4 years ago
12 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
7/22/2020 - 4 years ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/9/2020 - 4 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
7/8/2020 - 4 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
7/7/2020 - 4 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
7/7/2020 - 4 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/20/2020 - 5 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/20/2020 - 5 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
2/20/2020 - 5 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
2/13/2020 - 5 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/16/2019 - 5 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
11/13/2019 - 5 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP